Publication:
A new silent germline mutation of the TSH receptor: Coexpression in a hyperthyroid family member with a second activating somatic mutation

dc.contributor.authorGÖZÜ, HÜLYA
dc.contributor.authorÖNEŞ, TUNÇ
dc.contributor.authorsGozu, Hulya Iliksu; Mueller, Sandra; Bircan, Rifat; Krohn, Knut; Ekinci, Gazenfer; Yavuzer, Dilek; Sargin, Haluk; Sargin, Mehmet; Ones, Tunc; Gezen, Cem; Orbay, Ekrem; Cirakoglu, Beyazit; Paschke, Ralf
dc.date.accessioned2022-03-12T17:35:27Z
dc.date.accessioned2026-01-10T21:05:05Z
dc.date.available2022-03-12T17:35:27Z
dc.date.issued2008
dc.description.abstractBackground: Up to date, three thyroid-stimulating hormone receptor (TSHR) germline variants have been reported for which no functional consequences have been detected by in vitro characterizations. However, familial nonautoimmune hyperthyroidism and hot nodules are clearly associated with constitutively activating TSHR germline mutations. We describe a family with a new TSHR germline mutation that is associated with euthyroidism in 13 family members and hyperthyroidism in 1 family member. Methods: Mutation analysis of the TSHR gene was performed by denaturing gradient gel electrophoresis. TSHR constructs were characterized by determination of cell surface expression, 3'-5'- cyclic adenosine monophosphate ( cAMP) accumulation, and constitutive cAMP activity. Results: A novel TSHR germline mutation ( N372T) was found in a man who presented with thyrotoxicosis. The mutation was also detected in 13 family members, all of whom were euthyroid. Interestingly, an additional constitutively active somatic mutation ( S281N) was identified on the second parental TSHR allele of the hyperthyroid index patient. Linear regression analysis showed a lack of constitutive activity for N372T. Moreover, coexpression studies of N372T with S281N did not reveal any evidence for a functional influence of N372T on the constitutively active mutation ( CAM). Conclusions: N372T is unlikely to cause altered thyroid function. This is consistent with the finding that only the index patient with the additional somatic mutation S281N was hyperthyroid.
dc.identifier.doi10.1089/thy.2007.0335
dc.identifier.eissn1557-9077
dc.identifier.issn1050-7256
dc.identifier.pubmed18466076
dc.identifier.urihttps://hdl.handle.net/11424/229164
dc.identifier.wosWOS:000256240800004
dc.language.isoeng
dc.publisherMARY ANN LIEBERT, INC
dc.relation.ispartofTHYROID
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectSTIMULATING HORMONE-RECEPTOR
dc.subjectHUMAN THYROTROPIN RECEPTOR
dc.subjectAUTOSOMAL-DOMINANT HYPERTHYROIDISM
dc.subjectNON-AUTOIMMUNE HYPERTHYROIDISM
dc.subjectTOXIC THYROID-NODULES
dc.subjectNONAUTOIMMUNE HYPERTHYROIDISM
dc.subjectCONGENITAL HYPERTHYROIDISM
dc.subjectEXTRACELLULAR DOMAIN
dc.subjectFUNCTIONAL-CHARACTERISTICS
dc.subjectCONSTITUTIVE ACTIVATION
dc.titleA new silent germline mutation of the TSH receptor: Coexpression in a hyperthyroid family member with a second activating somatic mutation
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage508
oaire.citation.issue5
oaire.citation.startPage499
oaire.citation.titleTHYROID
oaire.citation.volume18

Files